Research Article

New Approach for Analysing the Discrepancy of Pretherapeutic Tc-99m and Intra-therapeutic I-131 uptake in Scintigraphies of Thyroid Autonomies using a Parametric 3D Analysis Program

Maaz Zuhayra, Marlies Marx, Ulrich Karwacik, Yi Zhao and Ulf Lützen*

Published: 01/02/2017 | Volume 1 - Issue 1 | Pages: 001-011

ABSTRACT

Introduction: Radioiodine therapy is a standard procedure in thyroid autonomy treatment. Discrepancies in the visual comparisons of the scintigraphies prepared for this purpose using Tc-99m-O4- and I-131 have been known for years.In this study a new method is used to calculate and perform a quantitative comparison of both uptakes using subtraction analysis and 3D imaging. The results and their causes are discussed together with practice-relevant conclusions for better clinical results.

Material and Methods: The new method was used in 38 patients with thyroid autonomies for the subtraction analysis of standardized pretherapeutic and intratherapeutic scintigraphies. The parametric distribution of activity was calculated absolutely and as a percentage and displayed three-dimensionally. These results were compared with the visual assessment of the different scintigraphies by the experts. Inclusion criteria were pretherapeutic and intratherapeutic hyperthyroidism without medication affecting the thyroid. The time difference between acquiring the scintigraphies was 28 days maximum.

Results: Activity distribution was visually discrepant in 39.5% of cases. 60.5% displayed comparable uptake. The calculated values showed reversed results after applying the new method. The results using our method show a higher rate of calculated discrepancies compared with visual analysis.

Conclusion: Accurate functional imaging of the thyroid is next to further aspects very important in establishing the diagnosis and deciding about the therapy activity for thyroid treatment. In combination with clinical symptoms and laboratory values, Tc-99m-O4 - scintigram can be used for an orientated, preliminary assessment of functional disorders of the thyroid. But because of the higher rate of found discrepancies, the solely use of Tc-99m-O4 - scintigram is not always capable for exact and reliable diagnosis. The known reason for this is most probably due to the different biokinetics of both radiopharmaceuticals, which can be imaged more sensitively with this method. Consequently, a scintigram should be performed in the pretherapeutic radioiodine uptake test. Despite higher costs and radiation exposure, alternatively, pretherapeutic use of other diagnostic iodine isotopes like I-123 or -124 should be discussed, because they could overcome the limitation of the different biokinetics. Following this approach the preliminary assessment using Tc-99m-O4 - scintigraphy can be precised and double checked to improve diagnostic confi dence and treatment results for a better outcome of the patients.

Read Full Article HTML DOI: 10.29328/journal.jro.1001001 Cite this Article

REFERENCES

  1. Schicha H, Schober O. Nuklearmedizin – Basiswissen Und Klinische Anwendung. Vol 7. ed. Stuttgart: Schattauer 2013.
  2. Dietlein M, Dressler J, Grünwald F, Leisner B, Moser E, et al. [Guideline for radioiodine therapy for benign thyroid diseases (version 4)]. Nuklearmedizin. 2007; 46: 220-223. Ref.: https://goo.gl/Rop4md
  3. Josef K. Methodik der szintigraphischen Diagnostik bei Schilddrüsen-autonomien. Der Nuklearmediziner. 1983; 3: 175-185.
  4. Thorsten Kuwert, Frank Grünwald, Uwe Haberkorn, Thomas Krause. Nuklearmedizin - Thieme.de - Thieme Webshop - Thorsten Kuwert, Frank Grünwald, Uwe Haberkorn, Thomas Krause. Thieme Webshop.
  5. Górowski T, Chomicki OA. Some comparative studies using 99mTc and 131I in thyroid scanning. Nuklearmedizin. 1976; 15: 268-272. Ref.: https://goo.gl/vQyqJ9
  6. Hotze L-A, Schumm-Draeger P-M, Pfannenstiel P. Schilddrüsenkrankheiten: Diagnose Und Therapie. Berliner Med. Verlag-Anst. BMV; 2003.
  7. Moser E. Results of radioiodine therapy in different forms of hyperthyroidism in relation to the planned dosage. Aktuelle Radiol. 1992; 2: 179-187. Ref.: https://goo.gl/tyPsTa
  8. Marinelli LD. Dosage determination in the use of radioactive isotopes. J Clin Invest. 1949; 28: 1271-1280. Ref.: https://goo.gl/HdLsXP
  9. Strahlenschutz in der Medizin - Richtlinie zur Strahlenschutzverordnung (StrlSchV) dated 26 May 2011 (GMBl. 2011, No. 44-47, p. 867), last amended by BMUB notice dated 11 July 2014 (GMBl. 2014, No. 49, p. 1020). 2011.
  10. Friston KJ, Holmes AP, Worsley KJ, Poline J-P, Frith CD, et al. Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp. 1994; 2: 189-210. Ref.: https://goo.gl/rjViBv
  11. Goris ML. Parametric images as a tool for quantitative normative evaluation. Semin Nucl Med. 1987; 17: 18-27.https://goo.gl/kPN6AK
  12. Kolbert KS, Hamacher KA, Jurcic JG, Scheinberg DA, Larson SM, et al. Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemia. J Nucl Med. 2001; 42: 27-32. Ref.: https://goo.gl/Lg8o4a
  13. Chen Q. Parametric imaging of patient pharmacokinetics. Eur J Nucl Med. 1997; 24: 1369-1373. Ref.: https://goo.gl/aqcX81
  14. Delorme S, Hoffner S. [Diagnosis of hyperparathyroidism]. Radiol. 2003; 43: 275-283. Ref.: https://goo.gl/LSiERH
  15. Schommartz B, Cupisti K, Antke C, Schmidt D, Knoefel WT, et al. Localisation of parathyroid glands using planar (99m)Tc-sestamibi scintigraphy. Comparison between subtraction- and dual-phase technique. Nuklearmedizin. 2006; 45: 115-121. Ref.: https://goo.gl/KH3n9Q
  16. Arnold JE, Pinsky S. Comparison of 99mTc and 123I for thyroid imaging. J Nucl Med. 1976; 17: 261-267. Ref.: https://goo.gl/3Qtx4K
  17. Atkins HL, Klopper JF, Lambrecht RM, Wolf AP. A comparison of technetium 99M and iodine 123 for thyroid imaging. Am J Roentgenol Radium Ther Nucl Med. 1973; 117: 195-201. Ref.: https://goo.gl/Zw4ZAZ
  18. Dige-Petersen H, Kroon S, Vadstrup S, Andersen ML, Roy-Poulsen NO. A comparison of 99Tc and 123I scintigraphy in nodular thyroid disorders. Eur J Nucl Med. 1978; 3: 1-4. Ref.: https://goo.gl/FAC3Bz
  19. Ryo UY, Vaidya PV, Schneider AB, Bekerman C, Pinsky SM. Thyroid imaging agents: a comparison of I-123 and Tc-99m pertechnetate. Radiology. 1983; 148: 819-822. Ref.: https://goo.gl/dfHujP
  20. Szonyi G, Bowers P, Allwright S, et al. A comparative study of 99mTc and 131I in thyroid scanning. Eur J Nucl Med. 1982; 7: 444-446. Ref.: https://goo.gl/bfxSiU
  21. Meller J, Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med Mol Imaging. 2002; 29 Suppl 2: S425-S438. Ref.: https://goo.gl/5uzxVX
  22. Schaub W. [Radioiodine studies with 1231]. Nukl Nucl Med. 1976; 15: 259-261. Ref.: https://goo.gl/H1n4IT
  23. Usher MS, Arzoumanian AY. Thyroid nodule scans made with pertechnetate and iodine may give inconsistent results. J Nucl Med Off Publ Soc Nucl Med. 1971; 12: 136-137. Ref.: https://goo.gl/6Pv9DD
  24. Freesmeyer M, Kühnel C, Westphal JG. Time effi cient 124I-PET volumetry in benign thyroid disorders by automatic isocontour procedures: mathematic adjustment using manual contoured measurements in low-dose CT. Ann Nucl Med. 2015; 29: 8-14. Ref.: https://goo.gl/H4nkHO